Navigation Links
Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium

NEW YORK, Oct. 8 /PRNewswire/ -- ExL Pharma, Cision and the PRSA have joined together to bring the pharmaceutical, medical device and biotech public relations executives the first Pharmaceutical Public Relations Symposium in conjunction with the PRSA 2007 International Conference. This one-day event will cover the key issues and challenges that these companies face in an industry that is under ongoing political and media scrutiny, most notably as we head into the 2008 election year.

The symposium offers perspectives from top pharmaceutical industry professionals representing companies such as: Pfizer, Wyeth, EMD-Serono, CCW Worldwide, Feinstein Kean Healthcare, Cision, ExL Pharma, and more. In addition, representatives from the FDA will speak on "Communicating More Effectively with the FDA" which will highlight key items on the FDA agenda in 2008. Topics of discussion will include enhancing corporate reputation, social responsibility, issues management, measurement of PR activities and merger or acquisition public relations strategies.

Bryon Main, Managing Director with ExL Pharma, had this to share about the upcoming event, "It is exciting to have partnered with PRSA and Cision to bring the pharmaceutical public relations professionals a one-day refresher symposium on top-of-mind issues for the industry as we head into 2008. This industry will be under even higher scrutiny in an election year and this event examines many key issues. We have a distinguished faculty ready to share ideas, as well as best practices, with attendees on how they can help improve the perception amongst key stakeholders."

The symposium is scheduled for October 23, 2007 at the Philadelphia Marriott hotel in downtown Philadelphia and is sponsored by PRSA Health Academy and CCW Worldwide. To view the full program agenda and/or to register, please visit

*Please mention keycode EXLPHARMA

About ExL Pharma

ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community. ExL Pharma is well known as the provider of the PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology, which is scheduled for its 4th run on July 14-15, 2008.

About the Public Relations Society of America (PRSA)

The Public Relations Society of America (, headquartered in New York City, is the world's largest organization for public relations professionals with nearly 32,000 professional and student members. PRSA is organized into 109 Chapters nationwide and 20 Professional Interest Sections and Affinity Groups, which represent business and industry, counseling firms, independent practitioners, military, government, associations, hospitals, schools, professional services firms and nonprofit organizations. The Public Relations Student Society of America (PRSSA) has 285 Chapters at colleges and universities throughout the United States.

About Cision:

Cision, formerly known as Bacon's, Delahaye and multivision, delivers the insight and media intelligence that improves communication performance and builds reputations. As a leading global provider of media research, distribution, monitoring and evaluation services, we ensure consistent global service; with the resources needed to grow with our clients and the public relations profession.

Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Visions, Part II: Preizler sees IT leading incremental health system change
2. Waisman director leading early stages of the Wisconsin Institutes for Discovery
3. NimbleGen partners with leading researchers
4. Leading global Big Pharma companies of 2005
5. Leading cancer institute to install three TomoTherapy systems
6. The worlds leading biotech companies
7. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
8. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
9. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
10. Deltanoid Pharmaceuticals begins phase II osteoporosis study
11. Doing the pharmaceutical tango
Post Your Comments:
(Date:10/9/2017)... , ... October 09, 2017 ... ... on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® ... gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
(Date:10/6/2017)... ... 2017 , ... The HealthTech Venture Network (HTVN) is proud ... annual Conference where founders, investors, innovative practitioners and collaborators are invited to a ... early stage digital health and med tech companies. , This day-long event will ...
(Date:10/5/2017)... YORBA LINDA, CA (PRWEB) , ... October 05, 2017 , ... ... tech innovators, engineers, and scientists from around the world, is giving back to cancer ... shirt sold in October. , Now through October 31, shoppers can use promo ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):